Annalise Enterprise CXR granted CE Mark under MDR class IIb for clinical use in EU
Update: Annalise.ai is now “Harrison-AI Medical Pty Ltd
We’re delighted to announce that Annalise Enterprise CXR has been granted CE Mark under MDR class IIb for clinical use in the European Union. Annalise Enterprise CXR is the most comprehensive AI decision-support solution for chest X-rays to have received CE Marking under MDR to date.
“The MDR Class IIb CE Marking is a more rigorous assessment of medical device patient safety for radiology in EU and its award is a testament to our commitment to deliver quality comprehensive solutions.” comments Dr Rick Abramson, Chief Medical Officer at annalise.ai.
About Harrison.ai
Harrison.ai is a global healthcare technology company that enhances clinician capacity and patient care through AI automation. Clinician-led and patient-first, our suite of solutions supports earlier, more accurate diagnoses and seamlessly integrates into clinical workflows.Harrison.ai solutions are available in 40+ countries and to half of all Australian radiologists. They are clinically deployed at 1,000+ customer sites globally, including 40+ NHS Trusts and all public emergency departments in Hong Kong. With 3,400+ clinicians using our tools, Harrison.ai has impacted more than 7 million patients’ lives to date.
